ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Essa Pharma Inc

Essa Pharma Inc (EPI)

8.20
0.00
( 0.00% )
Updated: 10:00:00

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
8.20
Bid
6.50
Offer
8.95
Volume
-
0.00 Day's Range 0.00
8.20 52 Week Range 8.20
Market Cap
Previous Close
8.20
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
44,100,000
Dividend Yield
-
PE Ratio
-10.30
Earnings Per Share (EPS)
-0.6
Revenue
-
Net Profit
-26.58M

About Essa Pharma Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Vancouver, British Columbia, Can
Founded
-
Essa Pharma Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker EPI. The last closing price for Essa Pharma was $8.20. Over the last year, Essa Pharma shares have traded in a share price range of $ 8.20 to $ 8.20.

Essa Pharma currently has 44,100,000 shares in issue. The market capitalisation of Essa Pharma is $361.62 million. Essa Pharma has a price to earnings ratio (PE ratio) of -10.30.

EPI Latest News

ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders

ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders Canada NewsWire HOUSTON and VANCOUVER, BC, Feb. 25, 2021 HOUSTON and VANCOUVER, BC, Feb. 25, 2021 /CNW/...

ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castr...

ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castration-Resistant Prostate Cancer Canada NewsWire HOUSTON and VANCOUVER...

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2020 Canada NewsWire VANCOUVER and HOUSTON, Dec. 15, 2020 VANCOUVER and...

ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference

ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference Canada NewsWire HOUSTON and VANCOUVER, BC, Nov. 25, 2020 HOUSTON and VANCOUVER, BC, Nov. 25, 2020 /CNW/ - ESSA Pharma...

ESSA Pharma Inc. Announces Delisting from the TSX-V

ESSA Pharma Inc. Announces Delisting from the TSX-V Canada NewsWire HOUSTON and VANCOUVER, BC, Oct. 26, 2020 HOUSTON and VANCOUVER, BC, Oct. 26, 2020 /CNW/ - ESSA Pharma Inc. ("ESSA" or...

ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium

ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium Canada NewsWire HOUSTON and VANCOUVER, BC, Oct. 24, 2020 HOUSTON and VANCOUVER, BC, Oct. 24, 2020 /CNW/...

ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia

ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia Canada NewsWire HOUSTON, Texas and VANCOUVER, BC, Oct. 19, 2020 HOUSTON, Texas and...

ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit

ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit Canada NewsWire HOUSTON and VANCOUVER, BC, Sept. 21, 2020 HOUSTON and VANCOUVER, BC, Sept. 21, 2020...

ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020

ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020 Canada NewsWire HOUSTON and VANCOUVER, BC, Sept. 17, 2020 HOUSTON and...

ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resist...

ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resistant Prostate Cancer Canada NewsWire HOUSTON and VANCOUVER, BC, Sept...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1008.28.28.200CS
4008.28.28.200CS
12008.28.28.200CS
26008.28.28.200CS
52008.28.28.200CS
156008.28.28.200CS
2604.0597.59036144584.1511.3447008.13464406CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
OZValkea Resources Corp
 0.40
(1,233.33%)
181.01k
FWTCForward Water Technologies Corp
$ 0.12
(1,100.00%)
35k
EGTEguana Technologies Inc
$ 0.01
(100.00%)
25k
VISVisionstate Corp
$ 0.05
(66.67%)
401.75k
ENTGEntourage Health Corp
$ 0.015
(50.00%)
1,000
BTVBlueRush Inc
$ 0.01
(-33.33%)
1,000
SSESilver Spruce Resources Inc
$ 0.01
(-33.33%)
374.33k
GBUGabriel Resources Ltd
$ 0.01
(-33.33%)
38.27k
APMIApogee Minerals Ltd
$ 0.055
(-26.67%)
5k
GBMLGlobal Battery Metals Ltd
$ 0.015
(-25.00%)
1.99k
NBLCNobel Resources Corp
$ 0.06
(20.00%)
2.16M
VOValOre Metals Corp
$ 0.08
(0.00%)
1.21M
SRISparton Resources Inc
$ 0.04
(33.33%)
1.2M
CMILCapella Minerals Ltd
$ 0.01
(0.00%)
910.53k
BFMBedford Metals Corp
$ 0.98
(-6.67%)
711.01k

Discussion

View Full Feed
Nebuchadnezzar Nebuchadnezzar 46 seconds ago
NVDA at $3 trillion has already priced all of 2025 in

that's what you all seem to forget

when the 50 day breaks down through the 150, this goes to $70s in 2025

NVDA chart is very similar to TSLA chart, once the biggest companies on earth have the chips th
NVDA TSLA
frans frans 50 seconds ago
nonsense
HNRC
motleytool motleytool 51 seconds ago
Remember .......naked shares dont exist so the amount you need to close out a naked position is the pre split number borrowed. Look at the bearish panic posts on all message boards. Yep Perfect set up!
SEEL
chilar4567 chilar4567 1 minute ago
jp, IMO the March 2.50 calls represent the most profitable strategy.
PAYS
Running Wild Running Wild 1 minute ago
Independent receiver..

On the call 👀



Juicy!



As The NSAV World Burns 🔥🔥🔥🔥

NSAV
falconer66a falconer66a 1 minute ago
No Schizo Patients Available?
Recruiting schizophrenic patients will be next to impossible now that KarTX is approved.
Really?

So, the tens of thousands of people suffering from schizophrenia are all going to be instantly taking KarTX, so no one with schizophrenia will b
AVXL
Nighthawk_1 Nighthawk_1 1 minute ago
Could it be possible that there is manipulation and insider information going on within the Dem arena? How would he know to sell prior to DOJ actions?
V
Arti3boy Arti3boy 1 minute ago
Busaca is not going to be the receiver
NSAV
koolmc koolmc 1 minute ago
.0018 up
SINC
threewheeler threewheeler 1 minute ago
AZRH .07s on the way today
AZRH
MoneyMan MoneyMan 2 minutes ago
Down goes .0017
SINC
RandomEvent1 RandomEvent1 2 minutes ago
If that’s your answer, yikes
RVNC
PennyMillions852 PennyMillions852 2 minutes ago
Wow look at all the ASK STACKS now...6.5mill at .0069, some real dumbasses out there...or scare tactics with fake walls.
IGPK
WALLnut WALLnut 2 minutes ago
Hope to hear from Doc today. And yes, lets move this pig north.



RDGL
RDGL
alertmeipp alertmeipp 2 minutes ago
Some funds have been pressuring the stock

I hope their plan is to get it done before q3 (end of sept)

Unlike RVNC, this company has excellent balance sheet and management.

The only thing I am not clear on is why some M&A or partnership still hasn’t happen
RVNC
ComstockRoyalty ComstockRoyalty 2 minutes ago
SUPER BULLISH NEWS -
Rare Element Resources Receives DOE Operations Approval and Additional Funding Commitment for Rare Earth Demonstration Plant in Wyoming
by Rare Element Resources | Sep 26, 2024
Operations Planned to Commence in 4Q 2024

September 26, 2024 – Li
REEMF
wshaw14 wshaw14 2 minutes ago
https://www.jpost.com/business-and-innovation/precious-metals/article-821915
BTG
TradeSmart.ai TradeSmart.ai 2 minutes ago
Moonnnnnboundddddd!!!! $SINC
SINC
Bearslayer Bearslayer 2 minutes ago
Would be nice to get up over 25 then consolidate for a day or two then move up to the next level. These shoot straight up moves always crash back down but the
Letting off of some steam helps with a longer sustained run.


IMO
SHIBUSD
MeteoricChimera43 MeteoricChimera43 2 minutes ago
Who else would be? Especially at that price flat lined for a month?
RVNC
Ms Labonte Ms Labonte 2 minutes ago
I want em cheapie$$$$$$$
RNAZ
vlispxpert vlispxpert 2 minutes ago
DOW breaking out...same with CVS! Both I found with a pattern I noticed yesterday...I did a screen using pattern & it spit these out...I think I found the golden eggs screen!! ;)

This screen finds breakouts short term, like 3-5 days, then sell for nice profit/scalp...stay tuned!
CVS
DesertDrifter DesertDrifter 2 minutes ago
The CNN/Playtone Tom Hanks/Spielberg series is a historical master work but as they say, there is more to the story to be told.
Bright Boy Bright Boy 2 minutes ago
Still super positive for the NWBO. From Hoffman:

This brings some legitimacy to these spoofing cases, imo. Market Makers are realizing that courts are willing to hear spoofing cases and MMs likely don't want to go to trial and disclose their sensitive trading data.

NWBO
RIGATONI RIGATONI 3 minutes ago
Here's a look >>>

Big run and fast last time, they put treasure on deck and ^^^

Check the last updates, I believe the entire site was being mapped out.

SFRX .0078

https://investorshub.advfn.com/uimage/uploads/2024/9/27/lyfjsSFRX.png
SFRX